Levine Mitchell S 4/A
4/A · OncoCyte Corp · Filed Dec 17, 2020
Insider Transaction Report
Form 4/AAmended
Levine Mitchell S
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-09-12$2.01/sh+10,000$20,060→ 13,495 total
Footnotes (2)
- [F1]The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018.